2''-O-RhamnosylswertisinCAS# 83889-78-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
Cas No. | 83889-78-5 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Yellow powder |
Formula | C28H32O14 | M.Wt | 592.5 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2''-O-Rhamnosylswertisin Dilution Calculator
2''-O-Rhamnosylswertisin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.6878 mL | 8.4388 mL | 16.8776 mL | 33.7553 mL | 42.1941 mL |
5 mM | 0.3376 mL | 1.6878 mL | 3.3755 mL | 6.7511 mL | 8.4388 mL |
10 mM | 0.1688 mL | 0.8439 mL | 1.6878 mL | 3.3755 mL | 4.2194 mL |
50 mM | 0.0338 mL | 0.1688 mL | 0.3376 mL | 0.6751 mL | 0.8439 mL |
100 mM | 0.0169 mL | 0.0844 mL | 0.1688 mL | 0.3376 mL | 0.4219 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Squamolone
Catalog No.:BCN0552
CAS No.:40451-67-0
- 2-Hydroxybenzylcyanide
Catalog No.:BCN0551
CAS No.:14714-50-2
- Methyl 2-(2,3-dihydroxyphenyl)acetate
Catalog No.:BCN0550
CAS No.:168481-87-6
- Chrysin 7-O-neohesperidoside
Catalog No.:BCN0549
CAS No.:35775-46-3
- Porphyroxine
Catalog No.:BCN0548
CAS No.:18104-24-0
- Dorsmanin I
Catalog No.:BCN0547
CAS No.:329703-46-0
- Trigonothyrin C
Catalog No.:BCN0546
CAS No.:1203471-31-1
- Ananolignan L
Catalog No.:BCN0545
CAS No.:1280213-70-8
- Trigochinin C
Catalog No.:BCN0544
CAS No.:1210299-33-4
- 6-Hydroxy-5,7,3',4',5'-pentamethoxyflavone
Catalog No.:BCN0543
CAS No.:29043-06-9
- Forestine
Catalog No.:BCN0542
CAS No.:91794-14-8
- 5-Hydroxy-1,7-diphenylhept-6-en-3-one
Catalog No.:BCN0541
CAS No.:155239-30-8
- Glochidiolide
Catalog No.:BCN0554
CAS No.:213528-23-5
- (19S,23E)-5β,19-Epoxy-19-methoxycucurbita-6,23,25-trien-3β-ol
Catalog No.:BCN0555
CAS No.:874287-87-3
- Velutinam
Catalog No.:BCN0556
CAS No.:146428-62-8
- Haplamide
Catalog No.:BCN0557
CAS No.:31991-78-3
- Falconeridine
Catalog No.:BCN0558
CAS No.:121880-22-6
- 14-O-Acetylsachaconitine
Catalog No.:BCN0559
CAS No.:102719-98-2
- Sachaconitine
Catalog No.:BCN0560
CAS No.:1361-02-0
- Philippin A
Catalog No.:BCN0561
CAS No.:1848254-99-8
- 2,3-Dihydroxybenzeneacetonitrile
Catalog No.:BCN0562
CAS No.:1513469-96-9
- Lespedezaflavanone H
Catalog No.:BCN0563
CAS No.:138822-59-0
- Glaucocalyxin A diacetate
Catalog No.:BCN0564
CAS No.:79498-37-6
- (19S,23R)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol
Catalog No.:BCN0565
CAS No.:1474062-47-9
Aleurites moluccanus and its main active constituent, the flavonoid 2''-O-rhamnosylswertisin, in experimental model of rheumatoid arthritis.[Pubmed:30769038]
J Ethnopharmacol. 2019 May 10;235:248-254.
ETHNOPHARMMACOLOGICAL RELEVANCE: Aleurites moluccana is used in folk medicine to treat pain, fever, asthma, hepatitis, gastric ulcer and inflammatory process in general, and the nut oil had been topically applied to treat arthritis and other joint pain, however the seeds are classified as toxic for oral use. AIM: Faced with the need for new alternative to treat the symptoms and modify rheumatoid arthritis (RA) the aim of this work was to evaluate the effects of A. moluccanus' leaves dried extract in rats and mice submitted to complete Freund adjuvant (CFA)-induced RA. MATERIAL AND METHODS: Wistar Rats and Swiss mice were submitted to CFA-induced RA in the right hindpaw. They received A. moluccanus extract (orally; p.o.), dexamethasone (subcutaneously), 2''-O-rhamnosylswertisin (p.o.) or vehicle (p.o.), from the 14th day after the CFA injection for up to 8 days. The mechanical hypersensitivity was evaluated using the von Frey filaments and the paw-oedema was measured using a plethysmometer. The rats' injected hindpaw was used to perform the histological analysis. RESULTS: A. moluccanus was able to significantly reduce the mechanical hypersensitivity in both ipsi- and contralateral hindpaws of mice injected with CFA, in a dose dependent manner. Furthermore, the paw-oedema was progressively reduced by A. moluccanus. Similar results were obtained for the positive-control drug dexamethasone and the isolated compound 2''-O-rhamnosylswertisin. Besides the effects mentioned above, the extract was also effective to repair the joint damage in CFA-induced RA rats, including reduction of fibrosis, cartilage degradation and bone erosion scores. CONCLUSION: These results together with the literature data reinforce the anti-hypersensitivity and anti-inflammatory activity of A. moluccanus extract. Part of the observed effects is due to the presence of the compound 2''-O-rhamnosylswertisin. The fact that the extract acted as a disease modifier point this herbal product as a promisor and safe tool to treat RA and other associated chronic diseases.
Aleurites moluccana and its main active ingredient, the flavonoid 2''-O-rhamnosylswertisin, have promising antinociceptive effects in experimental models of hypersensitivity in mice.[Pubmed:22626955]
Pharmacol Biochem Behav. 2012 Aug;102(2):302-11.
This study investigated the antinociceptive effect of Aleurites moluccana dried extract (DE; 125 to 500 mg/kg, p.o.) and the isolated flavonoid 2''-O-rhamnosylswertisin (5 to 50.6 mumol/kg, p.o.) using different models of long-lasting inflammatory and neuropathic pain in mice. Attempts were made to analyse the mechanisms through which A. moluccana exerted its effects. A. moluccana DE inhibited complete Freund's adjuvant (CFA)-induced mechanical nociception. It was also evidenced by a reduction of sensitization in the contralateral hindpaw. The extract reversed the mechanical hypersensitivity of partial ligation of sciatic nerve (PLSN)-treated animals, similar to gabapentin. In PLSN model, the opioid, dopaminergic and oxidonitrergic pathways were involved in the A. moluccana DE antinociceptive effects. A single dose of 2''-O-rhamnosylswertisin inhibited the carrageenan- and CFA-induced mechanical nociception. Furthermore, the compound caused expressive antinociception in PLSN-mice, with inhibition value greater than obtained with gabapentin. Oral treatment with the extract or the isolated compound attenuated the neutrophil migration and IL-1beta levels following carrageenan injection. Of note, A. moluccana DE did not interfere with thermal sensitivity in healthy mice. The absence of side effects, including interference in locomotor activity, motor performance in animals treated with the extract, showed excellent potential for the therapeutic use of this medicinal plant in treating persistent pain in humans.
Aleurites moluccana (L.) Willd. Leaves: Mechanical Antinociceptive Properties of a Standardized Dried Extract and Its Chemical Markers.[Pubmed:21660087]
Evid Based Complement Alternat Med. 2011;2011:179890.
Seeking to develop a new analgesic phytomedicine, a spray-dried extract (SDE) of Aleurites moluccana (L.) Willd. leaves was developed in scale up (5 kg). The SDE was standardized at 3% w/w in relation to the flavonoid 2''-O-rhamnosylswertisin. The SDE batches were evaluated in relation to their physical, physiochemical, and pharmacological characteristics. The results demonstrated the reproducibility of the scale up SDE process which, when dosed orally, reduced carrageenan-induced mechanical hypernociception, with an ID(50)% of 443 mg/kg. Similar results were obtained with animals injected with complete Freund's adjuvant (CFA), in which SDE caused inhibition of 48 +/- 4%. SDE was effective in preventing prostaglandin E2 (PGE2)-induced mechanical hypernociception (inhibition of 26 +/- 10% and 33 +/- 3%, at 250 and 500 mg/kg, respectively). Swertisin and 2''-O-rhamnosylswertisin isolated from the own extract were effective in inhibiting the hypernociceptive response induced by carrageenan (70 +/- 2% and 50 +/- 5%, resp.). Furthermore, 2''-O-rhamnosylswertisin was capable of significantly inhibiting the mechanical sensitization induced by CFA or PGE2, with inhibitions of 25 +/- 3% and 94 +/- 6%, respectively. These results suggest that the effects of SDE are related, at least in part, to the presence of these flavonoids.